Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant Melanoma

NCT02077114 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma With Metastasis

Interventions

BIOLOGICAL: Vaccine consisting of a peptide derived from the protein IDO

Sponsor

Herlev Hospital